Dechra Pharmaceuticals (DPH) Short Positions
Add to Alert list

Active Short Positions

Holder Position Change Date
No active short positions

Historical Short Positions

Holder Position Change (%) Date
Qube Research & Technologies Limited 0.53% -0.26 15-Jan-2024 View History
Qube Research & Technologies Limited 0.79% -0.1 10-Jan-2024 View History
Qube Research & Technologies Limited 0.89% -0.06 27-Dec-2023 View History
Qube Research & Technologies Limited 0.95% -0.12 20-Dec-2023 View History
Qube Research & Technologies Limited 1.07% -0.11 15-Dec-2023 View History
Qube Research & Technologies Limited 1.18% -0.11 11-Dec-2023 View History
Qube Research & Technologies Limited 1.29% -0.02 01-Dec-2023 View History
Qube Research & Technologies Limited 1.31% 0.02 30-Nov-2023 View History
Qube Research & Technologies Limited 1.29% -0.08 22-Nov-2023 View History
Qube Research & Technologies Limited 1.37% -0.12 09-Nov-2023 View History
Qube Research & Technologies Limited 1.49% -0.02 01-Nov-2023 View History
Qube Research & Technologies Limited 1.51% 0.11 18-Oct-2023 View History
Qube Research & Technologies Limited 1.4% 0.03 12-Oct-2023 View History
Qube Research & Technologies Limited 1.37% -0.03 10-Oct-2023 View History
Qube Research & Technologies Limited 1.4% 0.03 09-Oct-2023 View History
Qube Research & Technologies Limited 1.37% -0.03 06-Oct-2023 View History
Qube Research & Technologies Limited 1.4% 0.08 27-Sep-2023 View History
Qube Research & Technologies Limited 1.32% 0.03 21-Sep-2023 View History
Qube Research & Technologies Limited 1.29% -0.01 20-Sep-2023 View History
Qube Research & Technologies Limited 1.3% 0.02 19-Sep-2023 View History
Qube Research & Technologies Limited 1.28% -0.02 07-Sep-2023 View History
Qube Research & Technologies Limited 1.3% 0.01 05-Sep-2023 View History
Qube Research & Technologies Limited 1.29% -0.07 04-Sep-2023 View History
Qube Research & Technologies Limited 1.36% -0.04 24-Aug-2023 View History
Qube Research & Technologies Limited 1.4% 0.05 17-Aug-2023 View History
Qube Research & Technologies Limited 1.35% 0.23 15-Aug-2023 View History
Qube Research & Technologies Limited 1.12% 0.05 11-Aug-2023 View History
Qube Research & Technologies Limited 1.07% -0.03 10-Aug-2023 View History
Qube Research & Technologies Limited 1.1% 0.08 09-Aug-2023 View History
Qube Research & Technologies Limited 1.02% 0.1 03-Aug-2023 View History
Qube Research & Technologies Limited 0.92% 0.03 01-Aug-2023 View History
Qube Research & Technologies Limited 0.89% -0.02 31-Jul-2023 View History
Qube Research & Technologies Limited 0.91% 0.02 28-Jul-2023 View History
Qube Research & Technologies Limited 0.89% -0.05 21-Jul-2023 View History
Qube Research & Technologies Limited 0.94% -0.07 18-Jul-2023 View History
Qube Research & Technologies Limited 1.01% 0.08 29-Jun-2023 View History
Qube Research & Technologies Limited 0.93% 0.1 26-Jun-2023 View History
Qube Research & Technologies Limited 0.83% 0.12 20-Jun-2023 View History
Qube Research & Technologies Limited 0.71% 0.1 15-Jun-2023 View History
Qube Research & Technologies Limited 0.61% 0.11 08-Jun-2023 View History
Qube Research & Technologies Limited 0.5% -0.08 06-Jun-2023 View History
AQR Capital Management, LLC 0.51% 02-Jun-2023 View History
Qube Research & Technologies Limited 0.58% -0.11 02-May-2023 View History
Qube Research & Technologies Limited 0.69% -0.05 25-Apr-2023 View History
Qube Research & Technologies Limited 0.74% -0.07 24-Apr-2023 View History
Qube Research & Technologies Limited 0.81% 0.19 21-Apr-2023 View History
Qube Research & Technologies Limited 0.62% 0.08 18-Apr-2023 View History
WorldQuant LLC 0.59% -0.07 18-Apr-2023 View History
Qube Research & Technologies Limited 0.54% 17-Apr-2023 View History
WorldQuant LLC 0.66% -0.04 17-Apr-2023 View History

Dechra Pharmaceuticals is a global developer and marketor of eterinary pharmaceuticals and related products.

Based in Northwich, England. It was listed on the London Stock Exchange until it was acquired by EQT AB in January 2024.

Dechra share price was listed under the ticker DPH.

Note: This description is in part generated by AI and not an endorsement by or the opinion of Investegate
UK 100

Latest directors dealings